Review on chemical characteristics and toxicity via [National Institutes of Health (NIH)].
Ingestion can lead to severe clinical symptoms including headache, dizziness, nausea, vomiting, bluish skin (cyanosis), low blood pressure, nerve damage, coma, and respiratory failure. amygdalin
It has been studied for potential analgesic properties, though it is not a standard or recommended treatment for pain relief. 5. Toxicology and Safety Concerns Food and Drug Administration (FDA) has not approved
A disaccharide consisting of two glucose molecules, one benzaldehyde unit, and one hydrocyanic acid unit. one benzaldehyde unit
The U.S. Food and Drug Administration (FDA) has not approved amygdalin or Laetrile for the treatment of any medical condition, citing a lack of evidence for safety and effectiveness.
Oral consumption is considered particularly hazardous because gut bacteria significantly accelerate the release of cyanide into the bloodstream.
Some studies suggest potential antioxidant properties that might influence oxidative stress markers.